UNS share price going to be $1.2 in 12 months, page-57

First 57 Last

Share
Profile

Follow
Naish

2,061 Posts.

05/02/16

09:48

Post #: 16948078
Share

Originally posted by IndiJo ↑

The 2Q results show that the ramp still has not really started. The once they start selling devices has long been the real question and even with amgen money coming on board...IMO WILL continue to be an issue in 2016!

After all...

"Having long said that 2013 would be the inflection point for our business, I am pleased to have turned the corner. We are now entering a period of hyper-growth, and expect to generate accelerating, recurring revenue from an expanding base of customers," stated Mr. Alan Shortall, CEO of Unilife.

"Last month, we announced the first in a series of agreements with immediate revenue. This 15-year customization and supply contact for the EZMix dual-chamber syringe is with a U.S. based pharmaceutical company that we expect will generate up to $110 million in cumulative revenue.

"We are getting ready to announce our first major long-term supply contract for the Unifill syringe. This is a significant multi-year commercial supply contract with a major pharmaceutical customer that generates revenue immediately. Negotiations for this agreement are complete and all terms have been agreed upon, with the execution copy now being routed for signature by both parties. I expect this agreement will establish Unilife as one of the leading suppliers of prefilled syringes in our industry.

"With so many transformational agreements generating immediate revenue, we have no intention of doing any secondary stock offering that would cause significant dilution to existing shareholders. We have therefore agreed to preliminary terms with a major U.S. life science financing firm for a debt funding program that we expect to finalize later this month. Combined with the anticipated cash to be generated from new and existing customers, we expect this medium-term debt program to strengthen our balance sheet as we transition into strong and accelerating revenue growth," Mr. Shortall concluded.

Expand

IndiJo

IT just makes you shake your head.
How has he got away with all of this stuff.
As I said it frightened the hell out of me 6 mths ago hearing this kind of stuff.
How long does he keep doing it.
When do you believe anything he says.

UNS Price at posting: 25.5¢ Sentiment: Hold Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The winners & losers on market if negative gearing were gone

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The market's shrugged at China's stimulus measures all year. Why is this one different?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

There are more pages in this discussion • 11 more messages in this thread...

First 57 Last

Add UNS (ASX) to my watchlist

UNS share price going to be $1.2 in 12 months, page-57

Top Stories

KalGold rolls out detailed aeromagnetic survey across Pinjin project

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The winners & losers on market if negative gearing were gone

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The market's shrugged at China's stimulus measures all year. Why is this one different?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ACCC seeks Olam divestments before it can buy Namoi Cotton

Featured News